Posts by ericg
‘That moment has come and gone’ — leaders lament lost progress on diversity at BBJ panel
Boston Business Journal event panelists lamented lost progress in racial equity, discussed the city hosting the national NAACP convention and urged efforts to help newly arrived migrants. Read More
Read MoreBoston Park Plaza to become a Hilton brand hotel
The Boston Park Plaza, one of the city’s best known hotels at nearly a century old and among its largest, is about to become part of the Hilton brand. Read More
Read MoreChase’s Mass. deposits skyrocket, cracking top 10 list
Chase’s deposits jumped 364% from June 30, 2022, from $1.8 billion to $8.4 billion, according to FDIC days. This makes it the seventh-largest bank in the state, which is up from its No. 33 place in 2022. Read More
Read MoreUnion Square Donuts’ latest location, and more retail news
Union Square Donuts is the latest retailer to sign onto a rare newly-built project in Harvard Square. Here’s the latest on that and other Boston-area retail news. Read More
Read MoreCambridge startup using AI to rewrite literary classics for all reading levels
Co-founder Ethan Pierce told BostInno his startup’s AI platform can rewrite full books at different reading levels and in multiple languages. Read More
Read MoreForm D Friday: Generative AI-driven travel startup closes seed round
An MIT-born startup using generative AI to develop personalized tour guides is one of startups that caught our attention this week. Read More
Read MoreHaemonetics revenue hits record high amid global expansion
The company, founded in Natick in 1971, sells supplies for plasma and blood collection as well as for hospital services such as homeostasis, transfusion management and vascular closure and cell salvage products. Read More
Read MoreThe founder of investment firm Eventide has values. Just don’t call them ESG.
For this immigrant, tying his Christian faith to his mutual funds was natural investment strategy, and an easier combination than it may sound. Read More
Read MoreAt special FDA hearing, Intarcia’s twice-rejected drug-device combo gets another ‘no’
An advisory committee to the U.S. Food and Drug Administration unanimously rejected a drug-and-device combination made by a Boston biotech, which the agency had already rejected twice. Read More
Read MoreBizSpotlight: Creative Office Resources
Creative Office Resources (COR), a leading MillerK Read More
Read More